Login
$MDLN
$39.17 +$0.00 (0.0%) After hours

$MDLN SEC Filings

Filed On Filing
16 Nov 2026 Form 4: Liberman Alexander M., Chief Legal Officer

Received 798,680 shares as a grant or award · Exercised 1,271,078 Incentive Units of Medline Holdings, LP · Acquired 1,271,078 Common Units of Medline Holdings, LP (Option Exercise/Conversion) · 1 more

16 Nov 2026 Form 4: Laabs Amanda H., Chief Product Officer

Received 520,127 shares as a grant or award · Exercised 820,000 Incentive Units of Medline Holdings, LP · Acquired 820,000 Common Units of Medline Holdings, LP (Option Exercise/Conversion) ($12.4M) · 1 more

16 Nov 2026 Form 4: Golwas Douglas P, Chief Commercial Officer

Received 895,512 shares as a grant or award · Exercised 1,411,808 Incentive Units of Medline Holdings, LP · Acquired 1,411,808 Common Units of Medline Holdings, LP (Option Exercise/Conversion) ($21.3M) · 1 more

16 Nov 2026 Form 4: Boyle James M, Director

Received 2,516,260 shares as a grant or award · Exercised 4,052,948 Incentive Units of Medline Holdings, LP · Acquired 4,052,948 Common Units of Medline Holdings, LP (Option Exercise/Conversion) · 1 more

16 Nov 2026 S-1
13 Nov 2026 144/A
13 Nov 2026 SCHEDULE 13G
13 Nov 2026 144
06 Nov 2026 SCHEDULE 13G/A
04 Nov 2026 10-Q
04 Nov 2026 8-K: Results of Operations and Financial Condition

NORTHFIELD, Ill., Nov. 4, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline” or the “Company”) (Nasdaq: MDLN), the largest provider of medical-surgical (“med-surg”) products and supply chain solutions serving all points of care3, today rep...

30 Oct 2026 SCHEDULE 13G/A
21 Oct 2026 8-K: Regulation FD Disclosure

On October 14, 2026, Medline Inc. (the “Company”) initiated a voluntary field action involving the removal, discontinuation, and market exit of all Medline Brand beds, including homecare beds, bariatric beds, and long-term care beds, as ...

15 Oct 2026 8-K: Departure/Election of Directors or Officers; Compensation

On October 13, 2026, Joseph P. Baratta notified the Board of Directors (the “Board”) of Medline Inc. (the “Company”) of his decision to resign from the Board, effective as of December 31, 2026. Mr. Baratta’s decision coincides with his p...

13 Oct 2026 Form 4: Gic Private Ltd, 10% owner and 2 others

Sold 7,816,987 shares ($275M)

06 Oct 2026 Form 4: Gic Private Ltd, 10% owner and 2 others

Sold 9,717,940 shares ($336M) · Sold 1,688,690 shares ($60.4M) · Sold 9,272,000 shares ($325M)

21 Aug 2026 Form 4: Boyle James M, Director

Granted 764,252 Incentive Units of Medline Holdings, LP

21 Aug 2026 Form 4: Miller Stephen L, Chief Operating Officer

Granted 87,667 Incentive Units of Medline Holdings, LP

17 Aug 2026 Form 4: Gic Private Ltd, 10% owner and 2 others

Sold 1,500,000 shares ($53.7M) · Sold 100,000 shares ($3.58M)

11 Aug 2026 SCHEDULE 13G/A

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support